PharmaForce

What PharmaForce does

PharmaForce is a privately held 340B Third Party Administrator (TPA) operating as Pharma Force Group, LLC, headquartered in Wayne, Pennsylvania. Founded in 2017, the company delivers an integrated platform that helps covered entities—hospitals, health systems, FQHCs, and critical access hospitals—administer their 340B drug pricing programs through contract pharmacy network management, mixed-use split billing, manufacturer reporting, referral capture, patient savings cards, and home infusion capture. PharmaForce reports 3,400+ pharmacy partners and 350+ covered entities served, with a 95% customer retention rate, and has earned 3x Best in KLAS recognition along with SOC 2 Type II certification.

The platform is cloud-based and purpose-built for 340B complexity rather than adapted from general revenue cycle or BI tools. Core modules include Contract Pharmacy for real-time claim capture, Split Billing for order splitting and audit readiness, ClaimsConnect and ClaimsConnectPro for automated ESP, Beacon, Kalderos, and Truzo manufacturer reporting with API-based submission and financial reconciliation, Referrals+ for capturing referral prescriptions from outside prescribers, RxSavingsCard for patient pass-through savings, and Kareem AI as an embedded intelligence layer for continuous monitoring, anomaly detection, and conversational program oversight. Native integrations across manufacturer reporting portals and pharmacy switch data deepen interoperability.

PharmaForce generates revenue through subscription-based enterprise contracts with covered entities under annual billing, with quote-based pricing not publicly disclosed. The go-to-market is direct enterprise field sales targeting healthcare provider organizations, supported by dedicated implementation project managers and a 340B Customer Success function. The company also derives revenue from integrated Pharmacy Benefit Management (PBM) services that broaden drug spend control beyond 340B. The business is independently owned by its founding team and executive leadership, with no disclosed venture capital, private equity, or parent company affiliations.

Name

PharmaForce

Legal name

Pharma Force Group, LLC

Website

https://thepharmaforce.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

PharmaForce is a privately held 340B Third Party Administrator that provides contract pharmacy administration, split billing, manufacturer reporting, referral capture, and patient savings card solutions to 350+ hospitals, health systems, FQHCs, and critical access hospitals across the United States.

Ownership category

akta.pro rank

Product category

340B Program Management Software

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)

SIC

Services-Health Services (8000), Hospital & Medical Service Plans (6324)

akta.pro primary industry

340B Program Administration & Contract Pharmacy Services (HLAFALAL)

akta.pro secondary industries

PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools) (HLAEAKAL), Pharmacy Benefit Management (PBM) & Pharmacy Network Administration (HLAFALAI), Compliance, Reporting & Regulatory Administration (ERISA/ACA/No Surprises) (HLAEALAJ)

Keywords

• 340B program management
• Contract pharmacy administration
• Split billing software
• Manufacturer reporting automation
• Pharmacy benefit management

Headquarters

HQ city

Wayne

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. 340B TPA Services: Third-party administrator fees for 340B program management including contract pharmacy administration, split billing, claims processing, and manufacturer reporting. Revenue is generated through service contracts with covered entities (hospitals, health systems, FQHCs).
2. PBM Services: Integrated Pharmacy Benefit Management services that compound the value of 340B with broader cost control across the entire drug spend for covered entities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

PharmaForce operates a unified 340B Third Party Administrator (TPA) platform that delivers contract pharmacy administration, split billing, automated manufacturer reporting, referral prescription capture, patient savings cards, and an AI-powered program intelligence layer (Kareem AI) for covered entities such as hospitals, health systems, and Federally Qualified Health Centers. The platform combines purpose-built software with dedicated account management to help covered entities maximize capture rates, maintain HRSA compliance, and reduce administrative burden.

Product overview

PharmaForce is a unified 340B Third Party Administrator (TPA) platform delivering a full suite of interconnected tools for covered entities. The platform consists of Contract Pharmacy (full-service pharmacy network administration), Split Billing (in-house pharmacy order splitting), ClaimsConnect/ClaimsConnectPro (manufacturer reporting via ESP, Beacon, and other portals), Referrals+ (referral prescription capture), RxSavingsCard (patient savings pass-through), and Kareem AI (AI-powered program intelligence layer). All modules are designed to work together as a single platform with one accountable partner, share data natively, and operate within a unified workflow environment.

Differentiator

Problem solved

Functional benefit

Brands

• ClaimsConnect: Automated manufacturer reporting platform for 340B claims submission and processing via ESP and Beacon portals.
• ClaimsConnect Pro
• Referrals+
• RxSavingsCard
• Kareem AI

Products and services

• Contract Pharmacy Full-service 340B contract pharmacy administration covering claims processing, manufacturer restriction compliance, audit documentation, and pharmacy network management to maximize capture rates. Designed for hospitals, health systems, and FQHCs operating contract pharmacy networks.
• Split Billing 340B split billing software for hospitals with in-house pharmacies, providing complete control over order splitting, crosswalk accuracy, and audit readiness for DSH, CAH, and health system environments. Supports 2-way and 3-way splits, central distribution tracking, and advanced self-audit tools.
• ClaimsConnect Automated 340B manufacturer reporting platform that simplifies ESP, Beacon, and manufacturer data submissions while maintaining full program integrity with real-time submission status, financial reconciliation, and clean audit trails. Built for covered entities managing high-volume 340B claims submissions.
• ClaimsConnectPro Premium tier of ClaimsConnect offering integrated API-based reporting with automated data mapping, validation, file submission, delivery verification, and financial reconciliation on Beacon submissions. Designed for covered entities seeking fully automated manufacturer reporting.
• Referrals+ Referral capture solution that identifies and validates unknown prescriber claims from outside providers, combining switch data, human investigation, and configurable rules to recover 340B savings from referral prescriptions. Produces HRSA-defensible audit trails and typically delivers 10-30% referral capture rates.
• RxSavingsCard Branded patient savings card that extends 340B program value to patients at the point of dispense, reducing out-of-pocket costs and improving medication adherence while maintaining compliance and automatic compliance controls.
• Kareem AI Purpose-built 340B intelligence layer embedded across the entire program, providing continuous monitoring, anomaly detection, conversational assistance, and financial modeling for 340B program oversight. Includes knowledge retrieval, configuration management, compliance detection, and AI-powered program optimization.
• Home Infusion Home infusion capture and compliance module that identifies and captures home infusion 340B opportunities, providing full compliance documentation and program value visibility for covered entities seeking to capture this specialized segment.

Quantifiable outcome

• 3,400+ pharmacy partners and 350+ covered entities served with 95% customer retention rate
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability5 records

Feature5 records

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• CaptureRx: CaptureRx is a 340B TPA focused on contract pharmacy and reverse distribution for safety-net providers and FQHCs. It is a direct competitor in the same contract pharmacy and referral capture categories as PharmaForce's core modules.
• SunRx: SunRx is a 340B TPA offering contract pharmacy, split billing, and program management services to hospitals and FQHCs. It is a directly comparable competitor focused on smaller covered entities where PharmaForce also competes.
• Verity Solutions (Cardinal Health): Verity Solutions is a 340B TPA owned by Cardinal Health, offering split billing, contract pharmacy, and compliance services to covered entities. It competes head-to-head with PharmaForce for hospital and health system clients and shares pharma-distribution parent economics.
• Sentry Data Systems (Avita Pharmacy Solutions): Sentry Data Systems is a 340B TPA acquired by Avita, providing split billing, contract pharmacy, and analytics for covered entities. It is a directly comparable TPA competitor with overlap across PharmaForce's hospital, health system, and FQHC segments.
• Macro Helix (Cencora): Macro Helix is a long-standing 340B TPA serving hospitals and health systems, now owned by Cencora (formerly AmerisourceBergen). It is the most direct competitor to PharmaForce in contract pharmacy and split billing services and benefits from distribution-side leverage.
• RafterOne / 340B management platforms: RafterOne provides 340B management software including contract pharmacy and split billing capabilities for covered entities. It targets the same hospital and FQHC buyer as PharmaForce, making it a relevant direct peer in mid-market 340B software.

Broad incumbents

• Apexus (340B Prime Vendor Program): Apexus operates the federal 340B Prime Vendor Program and offers related consulting, education, and analytics services to 340B stakeholders. It is not a direct TPA competitor but a broad incumbent shaping how covered entities evaluate and procure TPA services.
• McKesson RxO (340B Solutions): McKesson offers 340B program management solutions through its broader pharmaceutical distribution and pharmacy services portfolio. As a top-tier pharma distributor, it competes with PharmaForce indirectly via bundled offerings and purchasing leverage at large hospital systems.

Emerging players

• Trellis Rx: Trellis Rx partners with health systems to build and operate specialty pharmacy programs, with significant 340B program overlap in high-cost and specialty drug categories. It is an emerging player that competes with PharmaForce's Specialty & High-Cost Drug Programs segment.
• Craneware (340B compliance solutions): Craneware provides 340B compliance, revenue cycle, and pharmacy supply chain solutions to hospitals and health systems. It overlaps with PharmaForce in 340B compliance and audit readiness but addresses adjacent financial and supply chain workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ThePharmaForce
• Facebookfacebook.com/thepharmaforce
• LinkedInlinkedin.com/company/pharmaforcellc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaForce